Company intelligence / Profile preview

ACLIV

Seoul, South Korea
Ownership
Private
Development stage
Other
01

Overview

ACLIV is a South Korean company commercializing antiviral and antibacterial surface-protection products, primarily films and coatings for touchscreens, handles, kiosks, mobile devices, vehicles, and medical-device surfaces. The company markets its technology as capable of rapidly reducing viral and bacterial contamination on treated surfaces and has highlighted certifications and regulatory clearances including ISO 21702 testing, CE marking, FDA-related claims, and a U.S. EPA registration for certain products. ACLIV appears to operate as both a brand and a corporate entity, while also being described in company materials as a business division associated with NEOTENY. Its business is centered on infection-control materials rather than therapeutic drug development, with commercialization focused on consumer, healthcare, and institutional surface applications. The company has reported collaborations with major enterprises and institutions, including pharmaceutical, medical-device, and NHS-related counterparties, although many partner names are not publicly disclosed.

Therapeutic areas
Infectious Diseases
Modalities
DeviceBiologic
Industry
Consumable Medical Devices
02

Partnerships

Undisclosed top-five European pharmaceutical companyUndisclosed major smartphone manufacturerNHS-related institutionsUndisclosed major European medical device supplier

Beyond the preview

Go deeper on ACLIV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACLIV.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call